Fig. 1.

Kaplan–Meier curves of overall survival estimates according to TRAIL, BAFF and APRIL serum levels, in patients with newly diagnosed acute myeloid leukaemia. Patients with TRAIL values higher (upper or black line) than median (38.54 pg/ml) have a significant longer OS than patients with lower TRAIL value (bottom line or red line). The two curves are significantly different (p = 0.03). Patients with BAFF values higher (bottom or black line) than median (3,615.14 pg/ml) have a significant shorter OS than patients with lower BAFF value (upper line or red line). The two curves are significantly different (p = 0.03). There were no differences of OS between patients with higher values of APRIL than median (5.96 ng/ml) compared to lower values, p = 0.6